XML 57 R44.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Taxes (Tables)
9 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of income arising in or derived from tax jurisdiction which each entity domiciled
Entity   Income Tax Jurisdiction
Jo-Jo Drugstores   United States
Renovation   Hong Kong, PRC
All other entities   Mainland, PRC
Schedule of components of income tax expense
   For the three months ended   For the nine months ended 
   December 31,   December 31, 
   2019   2018   2019   2018 
Current:                
Federal   -    -    -    - 
State   -    -    -    - 
Foreign   2,184    47,958    16,274    104,712 
    2,184    47,958    16,274    104,712 
                     
Deferred:                    
Federal   -    -    -    - 
State   -    -    -    - 
Foreign   -    -    -    -
    -    -    -    - 
Provision for income taxes   2,184    47,958    16,274    104,712

Schedule of reconciles the U.S. statutory tax rates with the Company's effective tax rate

   For the three months ended   For the nine months ended 
   December 31,   December 31, 
   2019   2018   2019   2018 
U.S. Statutory rates   21.0%   21.0%   21.0%   21.0%
Foreign income not recognized in the U.S.   (21.0)   (21.0)   (21.0)   (21.0)
China income taxes   25.0    25.0    25.0    25.0 
Change in valuation allowance (1)   (25.0)   (25.0)   (25.0)   (25.0)
Non-deductible expenses-permanent difference (2)   0.5    (2.2)   (0.5)   (2.4)
Effective tax rate   0.5%   (2.2)%   (0.5)%   (2.4)%

 

(1) Represents a non-taxable expense reversal due to overall decrease in allowance for accounts receivable and advances to suppliers.

 

(2) The 0.5% and (2.2)% rate adjustments for the three months ended December 31, 2019 and 2018 and the (0.5)% and (2.4)% rate adjustments for the nine months ended December 31, 2019 and 2018 represent expenses that primarily include stock option expenses and legal, accounting and other expenses incurred by the Company that are not deductible for PRC income tax.

 

Schedule of net deferred tax assets
  As of
December 31,
2019
   As of
March 31,
2019
 
         
Allowance   943,258    986,665 
Long-lived assets impairment   564,787    586,298 
Depreciation and Amortization   -    - 
Accrued expense   1,628,865    1,569,683 
Net operating loss carry forward   1,589,447    1,164,735 
Foreign Tax Credit Carryover   195,000    195,000 
Total deferred tax assets (liabilities):   4,921,357    4,502,381 
           
Valuation allowance   (4,921,357)   (4,502,381)
Net deferred tax assets (liabilities)   -    -